SearcharxivSearch

arXiv subjects

J. M. Gran

Publications and source records attributed to J. M. Gran.

3 recordsLinked to original sources

A hybrid landmark Aalen-Johansen estimator for transition probabilities in partially non-Markov multi-state models

Multi-state models are increasingly being used to model complex epidemiological and clinical outcomes over time. It is common to assume that the models are Markov, but the assumption can often be unrealistic. The Markov assumption is seldomly checked and violations can lead to biased estimation for many parameters of interest. As argued by Datta and Satten (2001), the Aalen-Johansen estimator of occupation probabilities is consistent also in the non-Markov case. Putter and Spitoni (2018) exploit this fact to construct a consistent estimator of state transition probabilities, the landmark Aalen-Johansen estimator, which does not rely on the Markov assumption. A disadvantage of landmarking is data reduction, leading to a loss of power. This is problematic for less traveled transitions, and undesirable when such transitions indeed exhibit Markov behaviour. Using a framework of partially non-Markov multi-state models we suggest a hybrid landmark Aalen-Johansen estimator for transition probabilities. The proposed estimator is a compromise between regular Aalen-Johansen and landmark estimation, using transition specific landmarking, and can drastically improve statistical power. The methods are compared in a simulation study and in a real data application modelling individual transitions between states of sick leave, disability, education, work and unemployment. In the application, a birth cohort of 184951 Norwegian men are followed for 14 years from the year they turn 21, using data from national registries.

stat.ME

Estimating the treatment effect on the treated under time-dependent confounding in an application to the Swiss HIV Cohort Study

When comparing time-varying treatments in a non-randomised setting, one must often correct for time-dependent confounders that influence treatment choice over time and that are themselves influenced by treatment. We present a new two step procedure, based on additive hazard regression and linear increments models, for handling such confounding when estimating average treatment effects on the treated (ATT). The approach can also be used for mediation analysis. The method is applied to data from the Swiss HIV Cohort Study, estimating the effect of antiretroviral treatment on time to AIDS or death. Compared to other methods for estimating the ATT, the proposed method is easy to implement using available software packages in R.

stat.ME

Dynamic models for estimating the effect of HAART on CD4 in observational studies: application to the Aquitaine Cohort study and the Swiss HIV Cohort Study

Highly active antiretroviral therapy (HAART) has proved efficient in increasing CD4 counts in many randomized clinical trials. Because randomized trials have some limitations (e.g., short duration, highly selected subjects), it is interesting to assess it using observational studies. This is challenging because treatment is started preferentially in subjects with severe conditions, in particular in subjects with low CD4 counts. This general problem had been treated using Marginal Structural Models (MSM) relying on the counterfactual formulation. Another approach to causality is based on dynamical models. First, we present three discrete-time dynamic models based on linear increments (LIM): the simplest model is described by one difference equation for CD4 counts; the second has an equilibrium point; the third model is based on a system of two difference equations which allows jointly modeling CD4 counts and viral load. Then we consider continuous time models based on ordinary differential equations with random effects (ODE-NLME). These mechanistic models allow incorporating biological knowledge when available, which leads to increased power for detecting treatment effect. Inference in ODE-NLME models, however, is challenging from a numerical point of view, and requires specific methods and softwares. LIMs are a valuable intermediary option in terms of consistency, precision and complexity. The different approaches are compared in simulation and applied to HIV cohorts (the ANRS CO3 Aquitaine Cohort and the Swiss HIV Cohort Study).

stat.ME